ChengDu ShengNuo Biotec Co.,Ltd.

SHSE:688117 Stock Report

Market Cap: CN¥4.3b

ChengDu ShengNuo BiotecLtd Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Yongjun Wen

Chief executive officer

CN¥748.8k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.2%
Management average tenure3.4yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) 27% Jump Shows Its Popularity With Investors

Mar 31
ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) 27% Jump Shows Its Popularity With Investors

ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 04
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

Aug 26
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)

Jun 19
A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)

ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues

Apr 29
ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues

There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump

Mar 04
There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump

CEO

Yongjun Wen (60 yo)

no data
Tenure
CN¥748,800
Compensation

Mr. Yongjun Wen serves as Chairman and General Manager at ChengDu ShengNuo Biotec Co., Ltd. he serves as a Consultant at Roton Capital Management Co., Ltd. Mr. Wen has experience in peptide drug CDMO proje...

Leadership Team

NamePositionTenureCompensationOwnership
Yongjun Wen
Chairman & GMno dataCN¥748.80k0.24%
CN¥ 10.5m
Xiaoli Wang
Director and Deputy General Managerno dataCN¥604.80k1.46%
CN¥ 62.9m
Changliang Lu
Deputy General Managerno dataCN¥528.80k0.25%
CN¥ 10.6m
Li Wu
CFO, Deputy GM & Director2.5yrsno datano data
Xiaohai Yu
Deputy GM3.4yrsno datano data
Zhonggang Ma
Deputy General Manager8.5yrsno datano data
3.4yrs
Average Tenure
53yo
Average Age

Experienced Management: 688117's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yongjun Wen
Chairman & GMno dataCN¥748.80k0.24%
CN¥ 10.5m
Xiaoli Wang
Director and Deputy General Managerno dataCN¥604.80k1.46%
CN¥ 62.9m
Li Wu
CFO, Deputy GM & Director2.5yrsno datano data
Xiaohai Yu
Deputy GM2.5yrsno datano data
Yafei Song
Director8yrsno datano data
Fasheng Wen
Director8.5yrsno datano data
Xia Liu
Independent Director2.5yrsCN¥72.00kno data
Dezhi Zeng
Chairman of the Supervisory Board8.5yrsno datano data
Jinshu Ren
Employee Representative Supervisor8.5yrsno datano data
Jingmeng Zhang
Employee Representative Supervisor11.5yrsno datano data
Zhengsong Xu
Independent Director1.4yrsno datano data
Yingkai Tang
Independent Director1.4yrsno datano data
5.3yrs
Average Tenure
48.5yo
Average Age

Experienced Board: 688117's board of directors are considered experienced (5.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/03 17:40
End of Day Share Price 2025/06/03 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ChengDu ShengNuo Biotec Co.,Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kai WangCitic Securities Co., Ltd.